Refine your search
Availability
-
Authors
-
Topics
- Adamantane
- Cost-Benefit Analysis
- Diabetes Mellitus, Type 2
- Dipeptides
- Dipeptidyl-Peptidase IV Inhibitors
- Drug Therapy, Combination
- Female
- Glycated Hemoglobin
- Humans
- Hypoglycemic Agents
- Insulin, Isophane
- Male
- Metformin
- Middle Aged
- Models, Economic
- Poland
- Quality-Adjusted Life Years
- Sulfonylurea Compounds
- analogs & derivatives
- blood
- Show more
- Show less
-
Languages